Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Chromosome 11 open reading frame 16 (C11orf16) is an uncharacterized, protein-coding gene in humans, located on chromosome 11p15.4, spanning base pairs 8,920,076–8,933,006. The gene encodes a predicted 467-amino acid protein of ~51 kDa, with multiple phosphorylation and glycosylation motifs, and is predicted to localize primarily to the nucleus or mitochondria. Tissue expression is generally low, with higher mRNA levels observed in the pancreas, ovary, and appendix. C11orf16 does not belong to any established receptor, enzyme, or structural protein family, has no described interacting drugs or well-defined biological function, and is not known to have a clear role in human diseases or to serve as a biomarker. Literature and public databases consistently list it as a protein of unknown molecular and biological function, and there is currently insufficient evidence to classify it as a therapeutic or pharmacological target.
None known
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Chromosome 11 open reading frame 16 (C11orf16).